CatalystPit

IMRXImmuneering Corp

NASDAQ · Pharmaceutical Preparations
Last close $4.09 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$106.22M
RECENT INSIDER TRADES
  • 2026-06-24 · Zeskind Benjamin J. (PRESIDENT AND CEO) · BUY
  • 2026-06-16 · Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) · BUY
  • 2026-03-17 · Neufeld Leah R (CHIEF PEOPLE OFFICER) · OTHER
  • 2026-01-21 · Brakewood Harold Eugene (Chief Business Officer) · BUY
  • 2026-01-20 · Schall Thomas J. (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders116
Shares held37,884,566
Value$179.90M
Percent of shares outstanding146.06%
As of quarter end2026-06-30
RECENT NEWS
  • Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
  • Immuneering presents pancreatic cancer data on atebimetinib at AACR conference
  • Immuneering to Present at the ESMO Congress 2026
  • Immuneering presents pancreatic cancer focus at H.C. Wainwright conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS